â– PHYSIOLOGICAL CORE: Senescent red blood cells are cleared and degraded by macrophages in the reticuloendothelial system (spleen, liver, bone marrow), requiring the processing of heme.
â– ENZYMATIC PROGRESSIONS:
1. Heme Cleavage: In macrophages, heme oxygenase cleaves the heme rings, producing biliverdin, iron (Fe2+), and carbon monoxide (CO).
2. Biliverdin Reduction: Cytosolic Biliverdin Reductase reduces the green pigment biliverdin into the yellow pigment unconjugated bilirubin.
3. Plasma Transit: Unconjugated bilirubin is water-insoluble, traveling through the bloodstream bound to plasma albumin to prevent tissue permeability.
4. Conjugation and Secretion: Hepatocytes absorb the bilirubin, conjugating it with glucuronic acid to produce water-soluble conjugated bilirubin for excretion.
â– ETIOLOGICAL PROFILE & RISK FACTORS:
Major etiological drivers include genetic predispositions (autosomal patterns and chromosomal translocations) and environmental triggers like toxic chemical exposure, mechanical stress, or chronic viral infections.
â– PROFESSOR'S CRITICAL SYNTHESIS:
Understanding the transition point from reversible cell injury to irreversible cellular death is the most fundamental concept in clinical medicine.
[HY-BOARD-1303]
🌟 Dynamic Clinical Key:
In patients with severe hemolytic anemia, rapid hemoglobin breakdown exceeds the liver's conjugation capacity. This results in elevations of unconjugated (indirect) bilirubin, presenting as clinical jaundice. Because unconjugated bilirubin is water-insoluble, it cannot be excreted in urine, resulting in absent urinary bilirubin. Assess family history and genetic screens to identify high-risk patients before symptoms present. Connect microscopic cellular structure with patient presentation to develop a unified diagnostic vision.